Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Nitazoxanide Plus Atazanavir/Ritonavir for COVID-19
NCT04459286Phase 2Terminated
- Sponsor
- Obafemi Awolowo University
- Start
- Oct 2020
- Primary completion
- May 2021
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of nitazoxanide, atazanavir, ritonavir in coronavirus disease 2019 (COVID-19), sponsored by Obafemi Awolowo University. Started Oct 2020; status: terminated.
02
Drugs
nitazoxanideatazanavirritonavir
03
Conditions
coronavirus disease 2019 (COVID-19)
Beyond the preview
Go deeper on NCT04459286.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04459286.